Analyst Consensus ?
ConsensusBuy39 ratings
Bullish3076.9%
Neutral923.1%
Bearish00.0%
FN2 Earnings Intelligence
Cigna Corporation complete analyst coverage
Cigna Corporation (CI) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$297.32Current
$225Low
$321.67Average
$415High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Bernstein | Outperform | Outperform | Maintain | Jul 9, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 8, 2026 |
| Barclays | Equal Weight | Overweight | Downgrade | May 26, 2026 |
| UBS | Buy | Buy | Maintain | May 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | May 20, 2026 |
| Deutsche Bank | Hold | Buy | Downgrade | May 20, 2026 |
| Guggenheim | Buy | Buy | Maintain | May 4, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 1, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | May 1, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | May 1, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 20, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Mar 3, 2026 |
| Truist Securities | Buy | Buy | Maintain | Feb 17, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 9, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Nov 4, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 4, 2025 |
| Baird | Outperform | Outperform | Maintain | Aug 14, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | May 5, 2025 |
| Stephens& Co. | Overweight | Overweight | Maintain | Jan 31, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jan 31, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 31, 2025 |
| Edward Jones | Hold | Buy | Downgrade | Aug 18, 2023 |
| B of A Securities | Buy | Buy | Maintain | Aug 4, 2023 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Feb 8, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 7, 2022 |
| Loop Capital | Hold | Hold | Maintain | Jun 17, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | May 9, 2022 |
| Seaport Global | Buy | Buy | Maintain | Nov 17, 2021 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 8, 2021 |
| Citigroup | Buy | Buy | Maintain | Feb 5, 2021 |
| Wedbush | Neutral | Neutral | Maintain | Nov 25, 2020 |
| Susquehanna | Outperform | Neutral | Upgrade | Nov 25, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Nov 25, 2020 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Nov 25, 2020 |
| Sterne Agee | Neutral | Buy | Downgrade | Nov 25, 2020 |
| Monness Crespi Hardt | Buy | Buy | Maintain | Nov 25, 2020 |
| Leerink Swann | Outperform | Outperform | Maintain | Nov 25, 2020 |
| Bank of America | Buy | Buy | Maintain | Nov 25, 2020 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Nov 5, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $297.32. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Analyst unavailable | $381 | $289.73 | +28.1% | Jul 8, 2026 |
| Wolfe Research | Justin Lake | $315 | $293.83 | +5.9% | Jun 16, 2026 |
| Mizuho Securities | Ann Hynes | $340 | $289.48 | +14.4% | Jun 8, 2026 |
| Barclays | Analyst unavailable | $304 | $286.24 | +2.2% | May 26, 2026 |
| UBS | Analyst unavailable | $400 | $282.02 | +34.5% | May 22, 2026 |
| Morgan Stanley | Analyst unavailable | $361 | $291.28 | +21.4% | May 20, 2026 |
| Deutsche Bank | Analyst unavailable | $302 | $291.28 | +1.6% | May 20, 2026 |
| Bernstein | Analyst unavailable | $371 | $279.35 | +24.8% | May 5, 2026 |
| Raymond James | Sarah James | $340 | $285.11 | +14.4% | May 1, 2026 |
| Robert W. Baird | Analyst unavailable | $337 | $285.6 | +13.3% | May 1, 2026 |
| Mizuho Securities | Analyst unavailable | $330 | $285.54 | +11.0% | May 1, 2026 |
| Barclays | Analyst unavailable | $310 | $290.58 | +4.3% | May 1, 2026 |
| Jefferies | Analyst unavailable | $330 | $278.64 | +11.0% | Apr 20, 2026 |
| Truist Financial | Analyst unavailable | $350 | $292.76 | +17.7% | Feb 17, 2026 |
| Deutsche Bank | Analyst unavailable | $304 | $291.17 | +2.2% | Feb 10, 2026 |
| Truist Financial | Analyst unavailable | $338 | $294.2 | +13.7% | Feb 9, 2026 |
| UBS | Analyst unavailable | $375 | $292.84 | +26.1% | Feb 9, 2026 |
| Barclays | Andrew Mok | $303 | $284.53 | +1.9% | Feb 6, 2026 |
| Mizuho Securities | Analyst unavailable | $325 | $283.91 | +9.3% | Jan 9, 2026 |
| Bernstein | Analyst unavailable | $307 | $287.1 | +3.3% | Jan 6, 2026 |
| Truist Financial | Analyst unavailable | $320 | $279.12 | +7.6% | Jan 5, 2026 |
| Barclays | Analyst unavailable | $305 | $279.12 | +2.6% | Jan 5, 2026 |
| Cowen & Co. | Charles Rhyee | $333 | $274.87 | +12.0% | Dec 15, 2025 |
| Guggenheim | Analyst unavailable | $318 | $273.57 | +7.0% | Dec 2, 2025 |
| Bernstein | Analyst unavailable | $294 | $271.57 | -1.1% | Nov 12, 2025 |
| UBS | Analyst unavailable | $294 | $268 | -1.1% | Nov 12, 2025 |
| Wells Fargo | Analyst unavailable | $300 | $264.66 | +0.9% | Nov 5, 2025 |
| Goldman Sachs | Scott Fidel | $330 | $258.62 | +11.0% | Nov 4, 2025 |
| Jefferies | David Windley | $310 | $244.41 | +4.3% | Nov 3, 2025 |
| Morgan Stanley | Erin Wright | $355 | $243 | +19.4% | Oct 31, 2025 |
| Barclays | Analyst unavailable | $300 | $245.1 | +0.9% | Oct 31, 2025 |
| Goldman Sachs | Scott Fidel | $370 | $295.41 | +24.4% | Oct 14, 2025 |
| Wells Fargo | Analyst unavailable | $354 | $302.99 | +19.1% | Oct 7, 2025 |
| Truist Financial | David MacDonald | $375 | $300.72 | +26.1% | Sep 2, 2025 |
| Robert W. Baird | Michael Ha | $372 | $286 | +25.1% | Aug 14, 2025 |
| Deutsche Bank | George Hill | $415 | $270.74 | +39.6% | Aug 5, 2025 |
| Guggenheim | Jason Cassorla | $388 | $333.82 | +30.5% | May 6, 2025 |
| Morgan Stanley | Erin Wright | $390 | $333.01 | +31.2% | May 5, 2025 |
| Barclays | Andrew Mok | $382 | $333.01 | +28.5% | May 5, 2025 |
| Wells Fargo | Stephen Baxter | $341 | $291.46 | +14.7% | Feb 4, 2025 |
| Piper Sandler | Jessica Tassan | $348 | $292.46 | +17.0% | Feb 3, 2025 |
| Raymond James | John Ransom | $360 | $294.21 | +21.1% | Jan 31, 2025 |
| Morgan Stanley | Erin Wright | $379 | $294.21 | +27.5% | Jan 31, 2025 |
| RBC Capital | Ben Hendrix | $355 | $294.21 | +19.4% | Jan 31, 2025 |
| Piper Sandler | Jessica Tassan | $400 | $338.8 | +34.5% | Jun 25, 2024 |
| Robert W. Baird | Michael Ha | $388 | $332.92 | +30.5% | May 29, 2024 |
| Jefferies | David Windley | $407 | $341.5 | +36.9% | May 6, 2024 |
| Oppenheimer | Michael Wiederhorn | $400 | $344.5 | +34.5% | May 3, 2024 |
| Raymond James | Sarah James | $400 | $344.5 | +34.5% | May 3, 2024 |
| RBC Capital | Ben Hendrix | $384 | $344.5 | +29.2% | May 3, 2024 |
| Raymond James | Sarah James | $372 | $324.06 | +25.1% | Feb 5, 2024 |
| Deutsche Bank | George Hill | $370 | $307.32 | +24.4% | Feb 1, 2024 |
| Leerink Partners | Analyst unavailable | $335 | $289 | +12.7% | Feb 8, 2023 |
| Raymond James | Analyst unavailable | $350 | $288.44 | +17.7% | Feb 7, 2023 |
| Stephens | Analyst unavailable | $370 | $289.12 | +24.4% | Feb 6, 2023 |
| Morgan Stanley | Analyst unavailable | $365 | $301.95 | +22.8% | Jan 6, 2023 |
| Morgan Stanley | Analyst unavailable | $347 | $320.9 | +16.7% | Nov 23, 2022 |
| Raymond James | John Ransom | $370 | $322.13 | +24.4% | Nov 6, 2022 |
| Truist Financial | David MacDonald | $330 | $272.63 | +11.0% | Jul 26, 2022 |
| Jefferies | David Windley | $271 | $273.75 | -8.9% | Jul 14, 2022 |
| Morgan Stanley | Ricky Goldwasser | $296 | $257.6 | -0.4% | Jun 22, 2022 |
| Deutsche Bank | George Hill | $284 | $244.52 | -4.5% | Jun 18, 2022 |
| Mizuho Securities | Ann Hynes | $291 | $263.98 | -2.1% | May 9, 2022 |
| Stephens | Analyst unavailable | $290 | $265.6 | -2.5% | Apr 20, 2022 |
| Truist Financial | David MacDonald | $290 | $254.12 | -2.5% | Apr 11, 2022 |
| Mizuho Securities | Ann Hynes | $266 | $240.51 | -10.5% | Mar 2, 2022 |
| Wells Fargo | Steve Baxter | $278 | $226.47 | -6.5% | Jan 6, 2022 |
| J.P. Morgan | Lisa Gill | $248 | $219.2 | -16.6% | Dec 21, 2021 |
| Goldman Sachs | Nathan Rich | $233 | $215.6 | -21.6% | Dec 14, 2021 |
| UBS | Kevin Caliendo | $244 | $216.63 | -17.9% | Nov 18, 2021 |
| Credit Suisse | A.J. Rice | $300 | $216.05 | +0.9% | Nov 8, 2021 |
| Evercore ISI | Michael Newshel | $230 | $211.09 | -22.6% | Nov 4, 2021 |
| Bank of America Securities | Kevin Fischbeck | $225 | $202.71 | -24.3% | Sep 10, 2021 |
| Cowen & Co. | Gary Taylor | $235 | $211.88 | -21.0% | Sep 9, 2021 |
| Raymond James | John Ransom | $275 | $208.14 | -7.5% | Aug 9, 2021 |
| Stephens | Scott Fidel | $270 | $206.32 | -9.2% | Aug 6, 2021 |
| Barclays | Steven Valiquette | $275 | $206.32 | -7.5% | Aug 6, 2021 |
| Oppenheimer | Michael Wiederhorn | $285 | $206.32 | -4.1% | Aug 6, 2021 |
| Cantor Fitzgerald | Steven Halper | $250 | $203.27 | -15.9% | Aug 5, 2021 |
| Wolfe Research | Justin Lake | $294 | $244.85 | -1.1% | Apr 26, 2021 |
Track every rating change on CI the moment it posts. Free to start.
Start free